Sutro Biopharma (STRO) Net Cash Flow (QoQ) (2018 - 2025)
Sutro Biopharma (STRO) Net Cash Flow (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -509.94% |
| Sep 30, 2025 | 104.51% |
| Jun 30, 2025 | 49.80% |
| Mar 31, 2025 | -634.62% |
| Dec 31, 2024 | -81.23% |
| Sep 30, 2024 | 227.69% |
| Jun 30, 2024 | 729.03% |
| Mar 31, 2024 | 67.65% |
| Dec 31, 2023 | 91.80% |
| Sep 30, 2023 | -188.78% |
| Jun 30, 2023 | 1,034.33% |
| Mar 31, 2023 | 130.73% |
| Dec 31, 2022 | -380.37% |
| Sep 30, 2022 | -64.82% |
| Jun 30, 2022 | 3,418.84% |
| Mar 31, 2022 | -416.38% |
| Dec 31, 2021 | 98.86% |
| Sep 30, 2021 | -4,574.74% |
| Jun 30, 2021 | 100.38% |
| Mar 31, 2021 | -206.03% |